Xi He Selected Research

Xi He Research Topics

Disease

53	Neoplasms (Cancer) 01/2022 - 03/2002
13	Inflammation (Inflammations) 07/2022 - 04/2010
12	Infections 01/2022 - 01/2016
10	Hypoxia (Hypoxemia) 01/2018 - 07/2009
8	Carcinogenesis 01/2020 - 03/2002
7	Obesity 01/2022 - 10/2014
7	Glioma (Gliomas) 01/2018 - 10/2011
6	COVID-19 01/2022 - 07/2020
6	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2015
6	Body Weight (Weight, Body) 09/2021 - 01/2017
6	Triple Negative Breast Neoplasms 01/2021 - 03/2017
5	Cardiomegaly (Heart Hypertrophy) 01/2021 - 01/2017
5	Diarrhea 01/2021 - 11/2018
5	Ischemia 04/2015 - 07/2009
4	Wounds and Injuries (Trauma) 03/2022 - 11/2020
4	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2017
4	Myocardial Infarction 09/2021 - 08/2010
4	Malaria 01/2021 - 01/2019
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 10/2002
4	Fibrosis (Cirrhosis) 01/2021 - 01/2017
4	Alzheimer Disease (Alzheimer's Disease) 02/2019 - 11/2009
4	Reperfusion Injury 11/2013 - 01/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2012
3	Colitis 01/2022 - 09/2021
3	Insulin Resistance 12/2021 - 09/2018
3	Non-alcoholic Fatty Liver Disease 07/2020 - 01/2017
3	Parkinson Disease (Parkinson's Disease) 10/2016 - 01/2013
2	Myopia 07/2022 - 01/2021
2	AIDS-Related Complex (ARC) 05/2022 - 08/2002
2	Adenocarcinoma of Lung 07/2021 - 11/2019
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2019
2	Myocardial Ischemia (Ischemic Heart Diseases) 08/2020 - 01/2011
2	Lung Neoplasms (Lung Cancer) 03/2020 - 01/2019
2	Vivax Malaria 01/2020 - 08/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019 - 09/2018

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 12/2021 - 07/2005
13	Pharmaceutical PreparationsIBA 01/2021 - 11/2009
12	beta CateninIBA 04/2010 - 03/2002
9	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2017 - 01/2013
8	LigandsIBA 07/2019 - 04/2004
8	MicellesIBA 02/2019 - 03/2015
7	Biological ProductsIBA 11/2021 - 06/2003
6	Peptides (Polypeptides)IBA 03/2022 - 11/2013
6	CytokinesIBA 03/2022 - 08/2002
6	Choline (Choline Chloride)IBA 01/2021 - 09/2015
5	CateninsIBA 12/2017 - 10/2011
4	Messenger RNA (mRNA)IBA 03/2022 - 11/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 04/2017
4	LipidsIBA 01/2022 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 04/2017
4	Interleukin-6 (Interleukin 6)IBA 12/2021 - 06/2017
4	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 07/2013
4	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 01/2021 - 03/2014
4	ProdrugsIBA 11/2018 - 01/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 05/2022 - 11/2018
3	VaccinesIBA 01/2022 - 10/2016
3	Small Interfering RNA (siRNA)IBA 01/2022 - 11/2013
3	Therapeutic UsesIBA 01/2022 - 01/2013
3	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 07/2015
3	Indicators and Reagents (Reagents)IBA 05/2021 - 10/2017
3	PlatinumIBA 01/2021 - 10/2017
3	CollagenIBA 11/2020 - 12/2017
3	PolyphenolsIBA 07/2020 - 12/2018
3	AcidsIBA 11/2019 - 11/2013
3	Glycoproteins (Glycoprotein)IBA 01/2019 - 09/2018
3	AntioxidantsIBA 01/2019 - 01/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 03/2015
2	Immunoglobulin M (IgM)IBA 05/2022 - 01/2020
2	Immunoglobulin A (IgA)IBA 05/2022 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 05/2022 - 01/2017
2	Dextran SulfateIBA 04/2022 - 09/2021
2	Dopamine (Intropin)FDA LinkGeneric 03/2022 - 11/2015
2	Caspase 3 (Caspase-3)IBA 03/2022 - 01/2013
2	EpitopesIBA 11/2021 - 01/2016
2	Monoclonal AntibodiesIBA 11/2021 - 01/2016
2	MicroRNAs (MicroRNA)IBA 11/2021 - 09/2018
2	Tumor Biomarkers (Tumor Markers)IBA 07/2021 - 01/2020
2	honokiolIBA 05/2021 - 01/2019
2	Cadherins (E-Cadherin)IBA 05/2021 - 03/2013
2	TRPC6 Cation ChannelIBA 01/2021 - 01/2018
2	CalciumIBA 01/2021 - 06/2012
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2011
2	HydrogelsIBA 01/2021 - 11/2020
2	alectinibIBA 01/2021 - 01/2021
2	human ERBB2 proteinIBA 01/2021 - 03/2017
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 11/2020 - 01/2011
2	MelatoninIBA 05/2020 - 01/2020
2	Immune Checkpoint InhibitorsIBA 03/2020 - 11/2019
2	Annexin A2 (Annexin II)IBA 01/2020 - 11/2019
2	APTIBA 11/2019 - 05/2018
2	TenascinIBA 11/2019 - 05/2018
2	NF-kappa B (NF-kB)IBA 11/2019 - 01/2019
2	Threonine (L-Threonine)FDA Link 10/2019 - 03/2002
2	Amino Acids FDA Link 10/2019 - 11/2018

Therapy/Procedure

28	Therapeutics 01/2022 - 03/2002
8	Drug Therapy (Chemotherapy) 01/2021 - 09/2015
3	Liver Transplantation 07/2020 - 05/2011
2	Stents 01/2022 - 09/2021
2	Immunotherapy 03/2020 - 01/2018